Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P722: Results of the STAR study: management of ulcerative colitis in private practice in france, in the first years following diagnosis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Bourreille*1, S. Nancey2, A. Attar3, H. Sokol4, L. Peyrin-Biroulet5, Y. Bouhnik6, X. Roblin7, G. Bonnaud8

1Hospital Hôtel-Dieu, Gastroenterology &Nutrition, Nantes, France, 2Centre Hospitalier LYON-SUD, Gastroenterology &Hepatology, Pierre-Bénite, Lyon, France, 3Private practice, Paris, France, 4Saint-Antoine Hospital, Gastroenterology and Nutrition, Paris, France, 5CHU of Nancy - Hôpitaux du Brabois, Gastroenterology and Hepatology, Vandoeuvre-lès-Nancy, France, 6Beaujon Hospital, Gastroenterology and Nutrition, Clichy, France, 7CHU 42 Hôpital Nord, Gastroenterology, St Priest en Jarez, Saint-Etienne, France, 8Private practice, Gastroenterology, Hepatology and Proctology, Colomiers, France

P723: Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with iron isomaltoside or ferric carboxymaltose: results of a prospective cluster randomised cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. E. Detlie*1,2, J. C. Lindstrøm3, M. E. Jahnsen1, E. Finnes4, H. Zoller5, B. Moum4,6, J. Jahnsen1,2

1Akershus University Hospital, Department of gastroenterology, Lørenskog, Norway, 2University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 3Akershus University Hospital, Health Services Research Unit, Lørenskog, Norway, 4Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 5Medical University of Innsbruck, Department of Medicine II, Gastroenterology and Hepatology, Innsbruck, Austria, 6Univeristy of Oslo, Institute of Clinical Medicine, Oslo, Norway

P724: Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Card*1, R. Ungaro2, F. Bhayat3, A. Blake3, G. Hantsbarger3, S. Travis4

1University of Nottingham, Faculty of Medicine and Health Sciences, Nottingham, UK, 2Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, USA, 3Takeda Pharmaceuticals International Co., Cambridge, USA, 4Oxford University Hospitals NHS Foundation Trust, Translational Gastroenterology Unit, Oxford, UK

P725: A prospective study of planned switch from Infliximab originator remicade to biosimilar inflectra: a multi-centre Irish experience

ECCO '19 Copenhagen

Year: 2019
Authors:

N. McGettigan*1, C. Mc Shane2, O. Mc Carthy1, A. Keogh1, D. Kevans2, E. Slattery1

1Galway University Hospital, Gastroenterology, Galway, Ireland, 2St James Hospital, Gastroenterology, Dublin, Ireland

P726: Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on infliximab maintenance therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

E. H. Oh*1, A-R. Yoon2, S. H. Park3, J. Kim1, N. Ham1, E. M. Song1, S. W. Hwang1,2, S. H. Park1,2, D-H. Yang1, J-S. Byeon1, S-J. Myung1, S-K. Yang1,2, B. D. Ye1,2

1Asan Medical Center, Gastroenterology, Seoul, South Korea, 2Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, South Korea, 3Asan Medical Center, Radiology, Seoul, South Korea

P727: Quality of life and disease activity in children and adolescents with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Aloi*1, E. Carloni1, F. Palmacci1, M. Distante1, G. Catassi1, G. D'Arcangelo1, S. Cucchiara1, AMICI Italian IBD Association1

1Sapienza University of Rome, Department of Pediatrics, Pediatric Gastroenterology Unit, Rome, Italy

P728: Effectiveness and quality of life (QoL) of Ustekinumab (UST) therapy in a Real-world Setting in Germany – First Results of the RUN-CD Study

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Bokemeyer*1,2, S. Plachta-Danielzik3, N. Teich4, W. Mohl5, M. Hoffstadt6, A. Schweitzer7, M. von der Ohe8, T. Krause9, J. Höchstödter3, P. Hartmann1, B. Wiebe3, S. Schreiber2

1Gastroenterology Practice, Minden, Germany, 2University Medical Center Schleswig-Hostein, Campus Kiel, I. Department Internal Medicine - General Internal Medicine, Kiel, Germany, 3Competence Network IBD, Kiel, Germany, 4Gastroenterology Practice, Leipzig, Germany, 5Gastroenterology Practice, Saarbrücken, Germany, 6Gastroenterology Practice, Iserlohn, Germany, 7Gastroenterology Practice, Münster, Germany, 8Gastroenterology Practice, Herne, Germany, 9Gastroenterology Practice, Kassel, Germany

P729: Faecal calprotectin and faecal immunochemical test have different values depending on mucosal status in patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

H. W. Kim*1, S. B. Park1, C. W. Choi1, D. H. Kang1, D. G. Ryu1

1Pusan National University Yangsan Hospital, Internal medicine, Yangsan, South Korea

P730: Short and long-term outcome of acute severe colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Marwa*1, M. Ghanem1

1Medical University of Tunis, Gastroenterology, Tunis, Tunisia

P731: Characteristics and follow-up on body composition, physical activity and quality of life in paediatric patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. K. Boros*1, O. Cseprekál2, K. E. Müller3, A. Dezsőfi1, G. Reusz1, G. Veres3

1Semmelweis University, Ist Department of Paediatrics, Budapest, Hungary, 2Semmelweis University, Ist Department of Medicine, Budapest, Hungary, 3University of Debrecen, Paediatric Institute-Clinic, Debrecen, Hungary

P732: Endoscopic Balloon Dilation Of Symptomatic Intestinal Crohn’s disease Strictures: Long-Term Data On Efficacy And Safety In A Cohort Of Patients Followed-up For 10 Years

ECCO '19 Copenhagen

Year: 2019
Authors:

D. Scimeca1, F. Mocciaro*1, R. Di Mitri1, M. Giunta2, S. Renna3, G. Teresi4, E. Conte1, A. Bonaccorso1, A. Casà3, M. Cottone5, A. Orlando3

1Gastroenterology and Endoscopy Unit, ARNAS Civico-Di Cristina-Benfratelli Hospital, Palermo, Italy, 2Gastroenterology Unit, Villa Sofia-Cervello Hospital, Palermo, Italy, 3IBD Unit, Villa Sofia-Cervello Hospital, Palermo, Italy, 4Internal Medicine, Villa Sofia-Cervello Hospital, Palrmo, Italy, 5Internal Medicine, Villa Sofia-Cervello Hospital, Palermo, Italy

P733: Comparative Analysis of Monotherapy and Combination Biological Therapy for Crohn’s disease and ulcerative colitis: Results from a Multi-Country Study in Europe

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Robinson*1, R. Bergman2, P. Collins1, C. Karki2, Y. Lu2

1Ipsos MORI, Global Healthcare Monitors, London, UK, 2Ipsos MORI, Global Healthcare Monitors, New York, USA

P734: Combining endoscopic and histological activity for predicting response to treatment

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Di Ruscio*1, A. Variola1, A. Geccherle1, G. Lunardi2, P. Castelli3, G. Zamboni3, R. Riddell4

1IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2IRCCS Sacro Cuore Don Calabria, Division of Medical Oncology, Negrar, Italy, 3IRCCS Sacro Cuore Don Calabria, Department of Pathology, Negrar, Italy, 4Mount Sinai Hospital University of Toronto, Department of Pathology and Laboratory Medicine, Toronto, Canada

P735: Immunogenicity differences between anti-TNF drugs

ECCO '19 Copenhagen

Year: 2019
Authors:

R. M. Gómez Espín*1, I. Nicolás de Prado1, C. Iniesta Navalón2, L. Rentero Redondo2, M. Gil Candel2, J. J. Martínez Crespo1

1HGU Reina Sofía, Gastroenterology, Murcia, Spain, 2HGU Reina Sofía, Pharmacology, Murcia, Spain

P736: Characteristics of polymeric formula and mode of delivery of exclusive enteral nutrition have no effect on disease outcome and weight gain in children with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Hojsak*1, I. Trivic1, S. Sila1, K. Matic2, Z. Misak1, S. Kolacek1

1Children's Hospital Zagreb, Zagreb, Croatia, 2University of Zagreb, School of medicine, Zagreb, Croatia

P737: SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

F. S. Macaluso*1, M. Cappello2, E. Giuffrida2, W. Fries3, A. Centritto3, A. C. Privitera4, G. Inserra5, R. Vassallo6, A. Magnano7, E. Vinci7, S. Garufi8, M. Ventimiglia1, S. Renna1, R. Orlando1, G. Rizzuto1, M. Cottone1, A. Orlando1

1IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy, 2Gastroenterology and Hepatology Unit, A.O.U. Policlinico ‘G. Giaccone’, Palermo, Italy, 3Inflammatory bowel disease Unit, A.O.U. Policlinico "G. Martino’, Messina, Italy, 4Inflammatory bowel disease Unit, A.O. "Cannizzaro’, Catania, Italy, 5Internal Medicine Unit, A.O.U. Policlinico ‘Vittorio Emanuele’, Catania, Italy, 6Gastroenterology and Endoscopy Unit, A.O. ‘Buccheri La Ferla Fatebenefratelli’, Palermo, Italy, 7Gastroenterology Unit, A.O.U. Policlinico ‘Vittorio Emanuele’, Catania, Italy, 8Gastroenterology Unit, A.O.O.R. ‘S. Elia- M. Raimondi’, Caltanissetta, Italy

P738: The budget impact of early dose optimisation with golimumab in ulcerative colitis in the UK

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Black*1, A. Hirst2, A. Brandtmüller3, S. Kachroo1, A. Puenpatom3

1Merck & Co., Inc., Kenilworth, USA, 2ICON PLC, Dublin, Ireland, 3MSD, Budapest, Hungary

P739: The progression of inflammatory bowel disease throughout Latin America: a systematic review

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Kotze*1, F. Underwood2, A. Damiao3, J. Ferraz2, R. Saad-Hossne4, M. Toro5, B. Iade6, F. Bosques-Padilla7, F. Teixeira8, F. Juliao-Baños9, D. Simian10, S. Ghosh11, R. Panaccione2, G. Kaplan2

1Catholic University of Paraná, IBD Outpatient Clinics, Colorectal Surgery Unit, Curitiba, Brazil, 2University of Calgary, Division of Gastroenterology and Hepatology, Calgary, Canada, 3University of Sao Paulo, Gastroenterology, Sao Paulo, Brazil, 4UNESP, Digestive Surgery, Botucatu, Brazil, 5Cuyo National University, Gastroenterology, Mendoza, Argentina, 6Hospital Maciel, Gastroenterology, Montevideo, Uruguay, 7Autonomous University of Nuevo Leon, Gastroenterology, Monterey, Mexico, 8Clinica Gastrosaude, IBD unit, Marilia, Brazil, 9Hospital Pablo Tobon Uribe, Gastroenterology, Medellin, Colombia, 10Clinica Las Condes, IBD unit, Santiago, Chile, 11NIHR Biomedical Research Centre, Institute of translational Medicine, Birmingham, UK

P740: Sexual quality of life in inflammatory bowel disease: a multi-centre, national-level study

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Roseira*1, F. Magro2, S. Fernandes3, C. Simões3, F. Portela4, V. Ana Isabel5, M. Patita5, C. Leal6, P. Lago7, P. Caldeira8, T. Gago8, P. Currais9, A. Sampaio10, C. Dias2, H. Tavares de Sousa11, GEDII1

1Centro Hospitalar Universitário do Algarve, Gastroenterologia, Portimão, Portugal, 2Hospital de São João, Porto, Portugal, 3Hospital de Santa Maria, Lisboa, Portugal, 4Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal, 5Hospital Garcia da Horta, Almada, Portugal, 6Centro Hospitalar de Leiria, Leiria, Portugal, 7Centro Hospitalar do Porto, Porto, Portugal, 8Centro Hospitalar Universitário do Algarve, Faro, Portugal, 9Instituto Português de Oncologia, Lisboa, Portugal, 10Associação Portuguesa da Doença Inflamatória do Intestino, Porto, Portugal, 11Centro Hospitalar Universitário do Algarve, Portimão, Portugal

P741: Fine-scale geographic distribution and ecological studies of Crohn’s disease in France (2007–2014)

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Genin*1, M. Fumery2, F. Occelli3, G. Savoye4, B. Pariente5, L. Dauchet6, C. Vignal7, M. Body-Malapel7, J. Giovannelli8, H. Sarter9, C. Gower-Rousseau8, G. Ficheur10

1University of Lille, EA2694 - Santé publique : épidémiologie et qualité des soins, Lille, France, 2Amiens University Hospital, Gastroenterology Unit, Amiens, France, 3University of Lille, EA 4483 - Impact de l’environnement chimique sur la santé humaine, Lille, France, 4Rouen University Hospital, Gastroenterology Unit, Rouen, France, 5Lille University Hospital, Gastroenterology Unit, Lille, France, 6Lille University hospital, INSERM, UMR1167, Lille, France, 7University of Lille, UMR 995, Lille, France, 8Lille University Hospital, UMR 995, Lille, France, 9Lille university Hospital, EA 2694 - Santé publique : épidémiologie et qualité des soins, Lille, France, 10Lille University Hospital, EA 2694 - Santé publique : épidémiologie et qualité des soins, Lille, France